Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma

Leuk Lymphoma. 2003 Jul;44(7):1249-50. doi: 10.1080/1042819031000079131.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • DNA (Cytosine-5-)-Methyltransferases / antagonists & inhibitors
  • DNA, Viral / analysis
  • Hepatitis B / drug therapy
  • Hepatitis B / etiology*
  • Hepatitis B virus / physiology*
  • Humans
  • Lamivudine / therapeutic use
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / virology
  • Male
  • Middle Aged
  • Remission Induction
  • Vidarabine / adverse effects*
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use
  • Virus Activation / drug effects*

Substances

  • Antineoplastic Agents
  • DNA, Viral
  • Lamivudine
  • DNA (Cytosine-5-)-Methyltransferases
  • Vidarabine
  • fludarabine